Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study

NCT04793568 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
109
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nantes University Hospital